Amyris is honored to be featured on the front page of The Minnesota Star Tribune business section as a biotechnology leader helping to shape the future of the bioeconomy. The article highlights Amyris CEO Kathy Fortmann and her vision for the company - one that combines strong business fundamentals and deep understanding of customer needs with unparalleled scientific innovation to scale precision fermentation into commercially viable, cost-competitive, and sustainable solutions that meet long-term business needs.

"By anticipating what customers might need next, then we’re faster to meet their needs." Kathy Fortmann, CEO

The piece underscores the industry's current inflection point, citing several of Amyris' most commercially successful molecules, including squalane, patchouli, and farnesene. As growing consumer demand for sustainable products drives brands to innovate and reformulate, Amyris provides a reliable alternative to traditional supply chains through its portfolio of 15 commercialized molecules. Looking ahead, we expect demand in beauty and pharmaceuticals, flavors and fragrances, food, and materials. As the article notes, "the bioeconomy is coming to life," and with decades of expertise, extensive testing, and over two decades of structured data gathered across the full technology stack, Amyris is positioned to lead through this inflection point, helping our customers grow responsibly and Unlock the Chemistry of Life.™

Read the full article here.

‍Contact us to learn more about how Amyris' capabilities can support your needs for innovative, scalable, and sustainable ingredients.